In a large-scale case–control study involving 727 patients with inflammatory bowel disease (IBD), there was a consistently observed association between the development of Crohn’s disease (CD) and the interleukin (IL)-23 receptor variant G149R. This evidence concerns the gene IL23R and inflammatory bowel disease.